Back

Management of new-onset atrial fibrillation in the intensive care unit: where do we stand?

17 May 2025 (08:55 - 09:45)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation and heart failure (1) Clinical HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Catarina Gregorio

Centro Hospitalar Universitário Lisboa Norte, Lisbon (Portugal)

4 More presentations in this session

Presentation thumbnail
Red cell distribution width and association with all-cause mortality: an easy-to-use and readily available biomarker in patients with atrial fibrillation and chronic heart failure
Doctor M. Vitolo (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Occult heart failure with preserved ejection fraction in atrial fibrillation: changes in HFA-PEFF-score and left atrial strain after cardioversion
Doctor R. Kumari (Bishkek, KG)
Abstract Slides Video
Presentation thumbnail
Longer postoperative atrial fibrillation correlates with higher recurrence of atrial fibrillation in patients with heart failure with reduced ejection fraction
Associate Professor M. Klinceva (Skopje, MK)
Abstract Slides Video
Presentation thumbnail
Arrhythmia-induced cardiomyopathy: clinical and echocardiographic characteristics compared to idiopathic dilated cardiomyopathy
Doctor A. Minghini (Genova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation and heart failure (1)

The Event

Event poster

Heart Failure 2025

17 May 2025 08:55 CET
You may be interested in
thumbnail
Congress Presentation
Timing of detection of atrial fibrillation recurrence in patients with transient new-onset atrial fibrillation detected during hospitalization for noncardiac surgery or medical illness
thumbnail
Congress Presentation
Predictors of new-onset in-hospital atrial fibrillation in 122 089 patients admitted with COVID-19: an Australian statewide population study
thumbnail
Congress Presentation
Permanent and persistent atrial fibrillation are independent risk factors of mortality after severe COVID-19

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources